JP2022553411A5 - - Google Patents
Info
- Publication number
- JP2022553411A5 JP2022553411A5 JP2022524134A JP2022524134A JP2022553411A5 JP 2022553411 A5 JP2022553411 A5 JP 2022553411A5 JP 2022524134 A JP2022524134 A JP 2022524134A JP 2022524134 A JP2022524134 A JP 2022524134A JP 2022553411 A5 JP2022553411 A5 JP 2022553411A5
- Authority
- JP
- Japan
- Prior art keywords
- activated
- population
- cells
- mncs
- ligand
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/660,442 | 2019-10-22 | ||
| US16/660,442 US10731128B2 (en) | 2016-11-22 | 2019-10-22 | Compositions and methods for in vitro activation and expansion of serial killer T cell populations and passive immunization of a cancer patient with tumor cell killing cells |
| PCT/US2020/056698 WO2021081115A1 (en) | 2019-10-22 | 2020-10-21 | Compositions and methods for in vitro activation and expansion of serial killer t cell populations and passive immunization of a cancer patient with tumor cell killing cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553411A JP2022553411A (ja) | 2022-12-22 |
| JP2022553411A5 true JP2022553411A5 (https=) | 2023-10-24 |
| JP7752424B2 JP7752424B2 (ja) | 2025-10-10 |
Family
ID=75619361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022524134A Active JP7752424B2 (ja) | 2019-10-22 | 2020-10-21 | シリアルキラーｔ細胞集団のインビトロ活性化及び拡大、ならびに腫瘍細胞殺傷細胞を有するがん患者の受動免疫化のための組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4048291A4 (https=) |
| JP (1) | JP7752424B2 (https=) |
| KR (1) | KR20220103928A (https=) |
| AU (1) | AU2020371619A1 (https=) |
| CA (1) | CA3154876A1 (https=) |
| IL (1) | IL292355A (https=) |
| MX (1) | MX2022004772A (https=) |
| WO (1) | WO2021081115A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113403274B (zh) * | 2021-06-28 | 2023-11-10 | 上海睿臻迈生物医疗科技有限公司 | 细胞治疗组合物及其制备方法和作为过敏性反应及自身免疫疾病治疗药物的应用 |
| CN114875069B (zh) * | 2022-04-22 | 2023-09-15 | 四川大学 | 基因工程修饰的il2细胞因子的重组载体、宿主细胞及其用途 |
| WO2024221005A2 (en) * | 2023-04-21 | 2024-10-24 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Methods for inhibiting resistance to immune blockade inhibitor therapy |
| CN116970562B (zh) * | 2023-09-22 | 2024-01-02 | 北京翊博生物集团有限公司 | 一种抗原特异性t细胞的制备方法及其在免疫治疗中的应用 |
| CN119320750A (zh) * | 2024-10-15 | 2025-01-17 | 南开大学 | Tnfsf15蛋白在制备促进肥大细胞激活的产品中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001231204A1 (en) * | 2000-01-27 | 2001-08-07 | Sidney Kimmel Cancer Center | Genetically engineered tumor cell vaccines |
| US7087225B2 (en) * | 2001-08-16 | 2006-08-08 | Human Genome Sciences, Inc. | Methods and compositions for treating metabolic bone diseases relating to human endokine alpha |
| MX2009006277A (es) * | 2006-12-14 | 2009-07-24 | Medarex Inc | Anticuerpos humanos que se enlazan a cd70 y usos de los mismos. |
| WO2011004201A1 (en) * | 2009-07-10 | 2011-01-13 | Mark Lowdell | Preserved compositions of activated nk cells and methods of using the same |
| US20180267024A1 (en) * | 2015-06-08 | 2018-09-20 | Lophius Biosciences Gmbh | Composition for determination of cell-mediated immune responsiveness |
| WO2017133175A1 (en) * | 2016-02-04 | 2017-08-10 | Nanjing Legend Biotech Co., Ltd. | Engineered mammalian cells for cancer therapy |
| KR20240024328A (ko) * | 2016-11-22 | 2024-02-23 | 알로플렉스 바이오테라퓨틱스 | 동종이형 종양 세포 백신 |
-
2020
- 2020-10-21 IL IL292355A patent/IL292355A/en unknown
- 2020-10-21 EP EP20879429.7A patent/EP4048291A4/en active Pending
- 2020-10-21 JP JP2022524134A patent/JP7752424B2/ja active Active
- 2020-10-21 MX MX2022004772A patent/MX2022004772A/es unknown
- 2020-10-21 WO PCT/US2020/056698 patent/WO2021081115A1/en not_active Ceased
- 2020-10-21 KR KR1020227013669A patent/KR20220103928A/ko active Pending
- 2020-10-21 CA CA3154876A patent/CA3154876A1/en active Pending
- 2020-10-21 AU AU2020371619A patent/AU2020371619A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7843056B2 (ja) | Ｔ細胞リンパ腫およびｔ細胞白血病に対するｃｄ２／５／７ノックアウト抗ｃｄ２／５／７キメラ抗原受容体ｔ細胞の使用 | |
| US20240261328A1 (en) | Use of cart19 to deplete normal b cells to induce tolerance | |
| JP2022553411A5 (https=) | ||
| KR102509006B1 (ko) | 세포 면역치료요법 전 세포독성 사전컨디셔닝의 대체 | |
| Edelson | Mechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation | |
| US20250090560A1 (en) | T cell receptors for immunotherapy | |
| Page et al. | Tolerogenic therapies in transplantation | |
| TW585915B (en) | Methods for activating natural killer (NK) cells | |
| JP2001520509A (ja) | 自己免疫細胞療法：細胞組成物、方法およびヒト疾患の治療への応用 | |
| AU2017311512B2 (en) | Cell therapy compositions and methods of use thereof | |
| EP2606125B1 (en) | Cells expressing th1 characteristics and cytolytic properties | |
| US10912798B2 (en) | Methods for treating an infectious or neoplastic disease | |
| AU2003260473B2 (en) | Use of dendritic cells (DCs) expressing interleukin 12 (IL-12) | |
| US20240226168A1 (en) | Engineered nk cells and uses thereof | |
| Jang et al. | Induction of cytotoxic T lymphocyte responses by cholera toxin-treated bone marrow-derived dendritic cells | |
| WO2023215825A1 (en) | Methods for improving t cell efficacy | |
| Haas et al. | An effective strategy of human tumor vaccine modification by coupling bispecific costimulatory molecules | |
| TW200908988A (en) | Therapeutic agent for cancer | |
| JP7768610B2 (ja) | Ｎｋｔ細胞を刺激する樹状細胞からなる樹状細胞製剤の製造方法 | |
| CA3202909A1 (en) | Formulations and processes for car t cell drug products | |
| Drawz et al. | Adoptive immunotherapy | |
| HK40069049A (en) | Lung cancer specific marrow infiltrating lymphocytes and uses thereof | |
| HK1257638A1 (en) | Cells expressing th1 characteristics and cytolytic properties | |
| EA045289B1 (ru) | Способ получения т-клеток | |
| Thompson | Murine acute myeloid leukemia cells expressing the cytosine deaminase gene induce protective immunity to parental leukemic cells |